Overall, out of 65 malignant neoplasms of the salivary glands, the evaluation regarding the expression of EpCAM was positive in 81.5%, with diversity regarding the proportion score (PS), intensity score (IS), and total immunostaining score (TIS). This evidence concerns the gene EPCAM and salivary gland cancer.